Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended? (Q41611517)

5 October 2017

Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended? (English)

1 reference

5 October 2017

3

Chris J L M Meijer

1 reference

5 October 2017

Margaretha A Vink

1

1 reference

5 October 2017

Johannes A Bogaards

series ordinal

2

1 reference

5 October 2017

Johannes Berkhof

series ordinal

4

1 reference

5 October 2017

language of work or name

English

0 references

publication date

17 December 2014

1 reference

International Journal of Cancer

5 October 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

5 October 2017

137

1 reference

5 October 2017

2

1 reference

5 October 2017

420-427

1 reference

Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.

5 October 2017

1 reference

Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.

21 January 2018

1 reference

Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data

21 January 2018

1 reference

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

21 January 2018

1 reference

Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies

21 January 2018

1 reference

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

21 January 2018

1 reference

Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination

21 January 2018

1 reference

The health and economic effects of HPV DNA screening in The Netherlands

21 January 2018

1 reference

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing

21 January 2018

1 reference

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

21 January 2018

1 reference

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

21 January 2018

1 reference

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.

21 January 2018

1 reference

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

21 January 2018

1 reference

Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus.

21 January 2018

1 reference

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women

21 January 2018

1 reference

The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.

21 January 2018

1 reference

Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy.

21 January 2018

1 reference

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

21 January 2018

1 reference

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis

21 January 2018

1 reference

Multiparameter Calibration of a Natural History Model of Cervical Cancer

21 January 2018

1 reference

Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model

21 January 2018

1 reference

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29381

1 reference

5 October 2017

1 reference